The TFRI-MOHCCN Technology Development Awards provides funding to projects to develop additional profiling technologies that would generate data compatible with precision oncology and could be applied to a section of the MOHCCN Gold Cohort.
When autocomplete results are available use up and down arrows to review and enter to select.
In a study published in the journal Value in Health in 2022, a team of health researchers that includes Marathon of Hope Cancer Centres Network (MOHCCN) members proposed a set of 68 core data elements...
"To broaden patient access to precision oncology, more evidence is needed to help decision makers determine what sequencing and treatment strategies should be made widely available," says Dr. Samantha Pollard.
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...